Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# $cocps

Moderna's norovirus vaccine faces delays, while $COCP's CDI-988 shows promise as an unchallenged antiviral. $COCP's Phase 1b study is set to begin dosing soon.

### About $cocps
$cocps refers to the social media presence and community surrounding a specific digital platform or service.  

### Engagements: X (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cocps/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cocps/time-series/interactions.tsv)  
Current Value: X  
Daily Average: XX  
X Week: X -XX%  
X Month: XX -XX%  
X Months: XXXXX -XX%  
X Year: XXXXX +558%  
1-Year High: XXXXX on 2025-10-03  
1-Year Low: X on 2025-01-15  

Engagements by network (24h):
X: X

  
  
### Mentions: X (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cocps/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cocps/time-series/posts_active.tsv)  
Current Value: X  
Daily Average: X  
X Week: X no change  
X Month: X no change  
X Months: X no change  
X Year: X +150%  
1-Year High: X on 2025-01-17  
1-Year Low: X on 2024-12-17  

Mentions by network (24h):
X: X

  
  
### Creators: X (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cocps/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cocps/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $cocps in the last XX hours which is no change from in the previous XX hours
Daily Average: X  
X Week: X no change  
X Month: X no change  
X Months: X no change  
X Year: X +100%  
1-Year High: X on 2024-12-17  
1-Year Low: X on 2024-12-17  

### Top $cocps Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Moderna's norovirus vax Ph3 hits another wall: low case accrual pushes readout to mid 2026+. Meanwhile $COCP's CDI-988 owning the lane. First-ever IND-cleared antiviral unchallenged in a $20B+ void. Ph1b challenge study dosing in weeks (topline Q1 '26)"  
[X Link](https://x.com/ms101phd/status/1988303382608830673) [@ms101phd](/creator/x/ms101phd) 2025-11-11T17:50Z XXX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$cocps

Moderna's norovirus vaccine faces delays, while $COCP's CDI-988 shows promise as an unchallenged antiviral. $COCP's Phase 1b study is set to begin dosing soon.

About $cocps

$cocps refers to the social media presence and community surrounding a specific digital platform or service.

Engagements: X (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
X Week: X -XX%
X Month: XX -XX%
X Months: XXXXX -XX%
X Year: XXXXX +558%
1-Year High: XXXXX on 2025-10-03
1-Year Low: X on 2025-01-15

Engagements by network (24h): X: X

Mentions: X (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
X Week: X no change
X Month: X no change
X Months: X no change
X Year: X +150%
1-Year High: X on 2025-01-17
1-Year Low: X on 2024-12-17

Mentions by network (24h): X: X

Creators: X (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $cocps in the last XX hours which is no change from in the previous XX hours Daily Average: X
X Week: X no change
X Month: X no change
X Months: X no change
X Year: X +100%
1-Year High: X on 2024-12-17
1-Year Low: X on 2024-12-17

Top $cocps Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Moderna's norovirus vax Ph3 hits another wall: low case accrual pushes readout to mid 2026+. Meanwhile $COCP's CDI-988 owning the lane. First-ever IND-cleared antiviral unchallenged in a $20B+ void. Ph1b challenge study dosing in weeks (topline Q1 '26)"
X Link @ms101phd 2025-11-11T17:50Z XXX followers, XXX engagements

$cocps
/topic/$cocps